Narratives

What's New

Your Valuation

Global Weekly Picks

Cue Biopharma

Lou_Basenese

Community Contributor

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Cue Biopharma bets its future on a new allergy drug designed by the same scientist who created Xolair, aiming to make treatment far less frequent for people with chronic hives and other allergic conditions. A key mid-stage trial result is coming soon, and it could either put Cue on big pharma’s radar or expose just how risky this turnaround really is.

View narrative

US$70

59.1% undervalued

217

AST SpaceMobile

HedgeY

Community Contributor

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

AST SpaceMobile is moving from demos to putting real satellites in orbit to bring phone service to regular smartphones in places where towers can’t reach. Big carrier tie-ups and early government work add credibility, but the plan still hinges on flawless launches and smooth rollout in a crowded satellite race.

View narrative

US$170

30.5% undervalued

365

Onto Innovation

FundamentalFlow

Community Contributor

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

A little-known step in making AI chips work at scale is turning into a bottleneck: stacking and checking chips and memory so they don’t fail. Onto Innovation may sit right in that chokepoint thanks to a key customer qualification and growing demand from AI memory makers, but delays, tougher competition, or export rules could still derail the story.

View narrative

US$380

26.8% undervalued

19.93%

Revenue growth p.a.

230

Nu Holdings

martinarauz

Community Contributor

Investment Analysis (May 2026)

Nu Holdings takes a hit as Brazil’s economy weakens and loan losses rise, but the core idea stays the same: a branch-free bank that keeps gaining customers and selling them more services. The next chapters—getting bigger in Mexico, testing new AI-driven advice, and a possible move into the U.S.—could change how investors see the business, but there are real risks tied to Brazil and credit quality.

View narrative

US$22.74

47.5% undervalued

24.00%

Revenue growth p.a.

440

Aoyama Zaisan Networks CompanyLimited

Preparing for re-acceleration in FY12/27

Aoyama Zaisan Networks pushes through a short-term bump from Japan’s tax rule changes as customer demand comes back quickly and new projects fill fast. Growth now leans on expanding its consulting footprint, getting more out of the Chester Group tie-up, and using tech and AI to help advisers serve more clients as Japan’s aging wealth shifts hands.Read more

JP¥1.31k

0.6% undervalued

AstrisCorporateAdvisory's

Fair Value

Revenue

6.59% p.a.

Profit Margin

6.58%

Future PE

11.75x

Price in 2031

JP¥1.84k

Diversified Energy

Diversified Energy's Profit Margin Set to Skyrocket 27%

PLEASE NOTE THAT THIS IS A SIMPLE AND HONEST SHARING OF EXPERIENCE AND BASIC KNOWLEDGE, ONLY. I am managing my own investments, and have been doing so for a few years.Read more

UK£7.27k

99.9% undervalued

Miracleworker's

Fair Value

Revenue

277% p.a.

Profit Margin

27.37%

Future PE

2.05x

Price in 2031

UK£11.61k

Barclays

Why Is Barclays Trading Below Book Value?

Barclays is currently trading at a price-to-book ratio of around 0.8, depending on the source used. In simple terms, this means that for every £100 of net assets attributable to shareholders on Barclays' balance sheet, the market is valuing those assets at approximately £80.Read more

UK£5.64

18.5% undervalued

Robbo's

Fair Value

Revenue

8.65% p.a.

Profit Margin

23.04%

Future PE

10.2x

Price in 2031

UK£8.35

Micron Technology

Micron Technology (MU): Riding the AI Supercycle to a $100B+ Revenue Horizon and Historic 40%+ Net Profit Margins

Micron is no longer just riding the usual ups and downs of the memory chip business, as booming demand from AI systems pushes it toward higher-value products and stronger pricing. The big question is whether its next wave of AI-focused memory can keep ramping smoothly while the stock already assumes very strong execution.Read more

US$1.25k

14.7% undervalued

DCA_rules's

Fair Value

Revenue

29% p.a.

Profit Margin

44%

Future PE

27x

Price in 2031

US$2.1k

Freegold Ventures

Freegold Ventures, Eric Sprott is Betting Big on This 31 Moz Alaska Gold Beast

A little-known gold explorer in Alaska is trying to turn a huge, road-accessible deposit near Fairbanks into a real mine, with a well-known resource investor backing it. The big question is whether upcoming engineering work can turn that scale into a buildable plan without nasty surprises in processing, permits, or funding.Read more

CA$33.01

96.4% undervalued

RockeTeller's

Fair Value

Profit Margin

9.45%

Future PE

15.43x

Price in 2031

CA$45.83

Lumentum Holdings

Lumentum: An AI-Fueled Recovery That Has Not Yet Earned Its $74 Billion Tag

I. Industry and Business Model Analysis Lumentum is a photonics manufacturer — it designs and produces the lasers, optical chips, modules, and subsystems that move data through fiber-optic networks.Read more

US$5.09k

79.8% undervalued

Edward_Sterling's

Fair Value

Revenue

50.98% p.a.

Profit Margin

17.64%

Future PE

182.39x

Price in 2031

US$7.71k

Wise Group

Wise: A Quality Cross-Border Payments Compounder, But Not A Bargain

Risks Growth is slowing compared with the past. Profit is partly supported by interest income from customer balances.Read more

UK£12.02

32.6% undervalued

cjimi's

Fair Value

Revenue

12% p.a.

Profit Margin

22.49%

Future PE

25x

Price in 2031

UK£16.59

Alphabet

Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late.

Ben Graham taught a generation of investors one sentence that has made more money than any chart ever printed. Price is what you pay.Read more

US$230

57.3% overvalued

tripledub's

Fair Value

Revenue

14.87% p.a.

Profit Margin

26%

Future PE

16x

Price in 2036

US$569.81

Nippn

Do not mistake depreciation for deterioration

Q4 FY3/26 results update More improvements to come – FY3/26 results were ahead of guidance, driven by efficiency gains at the Flour Milling segment. The Food segment saw growth, but profitability was impacted by cost pressures.Read more